blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4125964

EP4125964 - COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  06.01.2023
Database last updated on 03.09.2024
FormerThe international publication has been made
Status updated on  02.10.2021
Most recent event   Tooltip28.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
University of Utah Research Foundation
615 Arapeen Drive, Suite 310
Salt Lake City, UT 84108 / US
[2023/06]
Inventor(s)01 / JAVAN, Hadi
3761 S. 300 E. South
Salt Lake City, Utah 84115 / US
02 / SELZMAN, Craig H.
2335 East 900 South
Salt Lake City, Utah 84108 / US
03 / LEE, Young Sook
241 North Vine Street
Salt Lake City, Utah 84103 / US
04 / REEMS, Jo-Anna
201 E South Temple, 6th Floor, Apt. 606
Salt Lake City, Utah 84111 / US
05 / PIERCE, Jan L.
1762 Sunrise Park Drive
Sandy, Utah 84093 / US
 [2023/06]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2023/06]
Application number, filing date21776017.222.03.2021
[2023/06]
WO2021US23511
Priority number, dateUS202062993614P23.03.2020         Original published format: US 202062993614 P
[2023/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021194983
Date:30.09.2021
Language:EN
[2021/39]
Type: A1 Application with search report 
No.:EP4125964
Date:08.02.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 30.09.2021 takes the place of the publication of the European patent application.
[2023/06]
Search report(s)International search report - published on:US30.09.2021
(Supplementary) European search report - dispatched on:EP13.03.2024
ClassificationIPC:A61K35/50, A61K9/00, A61P9/10, A61P43/00, A61K31/728, A61K38/01, A61K45/06
[2024/15]
CPC:
A61K45/06 (EP,US); A61K35/50 (EP,US); A61K31/728 (EP,US);
A61K38/014 (EP,US); A61K9/0019 (EP,US); A61P43/00 (EP,US);
A61P9/10 (EP,US) (-)
C-Set:
A61K31/728, A61K2300/00 (EP);
A61K35/50, A61K2300/00 (EP);
A61K38/014, A61K2300/00 (EP)
Former IPC [2023/06]A61K35/50, A61K9/00, A61P9/10, A61P43/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/06]
TitleGerman:ZUSAMMENSETZUNGEN UND BEHANDLUNGEN FÜR ISCHÄMISCHE VERLETZUNGEN[2023/06]
English:COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES[2023/06]
French:COMPOSITIONS ET TRAITEMENTS POUR DES LÉSIONS ISCHÉMIQUES[2023/06]
Entry into regional phase23.09.2022National basic fee paid 
23.09.2022Search fee paid 
23.09.2022Designation fee(s) paid 
23.09.2022Examination fee paid 
Examination procedure23.09.2022Examination requested  [2023/06]
17.04.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.03.2023Renewal fee patent year 03
27.03.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2016199417  (WERBER BRUCE [US], et al) [X] 10-13 * the whole document * * paragraphs [0050] , [0 55]; claims 1-59 *;
 [XY]US2018015128  (BRITT EDWARD [US]) [X] 1-5,10-12 * claims 1, 9 * * figures 1-3 * * paragraphs [0003] , [00 8] , [0 14] , [0 15] , [0 69] , [0 77] * * the whole document * [Y] 1-15;
 [X]US10517903  (BEAUDRY CHRISTIAN [US], et al) [X] 10-13 * the whole document * * claim 1 * * columns 13-14 *;
 [T]WO2021202947  (UNIV UTAH RES FOUND [US], et al) [T] * the whole document * * page 6, lines 19-23 *;
 [T]WO2021205411  (ORGANICELL REGENERATIVE MEDICINE INC [US]);
 [Y]  - BALBI C ET AL, "The human amniotic fluid stem cell secretome as new paracrine source to unlock endogenous cardiac regeneration", VASCULAR PHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, (20180418), vol. 103, doi:10.1016/J.VPH.2017.12.004, ISSN 1537-1891, pages 47 - 48, XP085382796 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.vph.2017.12.004
 [Y]  - BOLLINI SVEVA ET AL, "Amniotic Fluid Stem Cells Are Cardioprotective Following Acute Myocardial Infarction", STEM CELLS AND DEVELOPMENT, US, vol. 20, no. 11, doi:10.1089/scd.2010.0424, ISSN 1547-3287, (20111101), pages 1985 - 1994, URL: http://dx.doi.org/10.1089/scd.2010.0424, XP093087153 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1089/scd.2010.0424
 [Y]  - MIRABELLA TEODELINDA ET AL, "Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 32, no. 15, doi:10.1016/J.BIOMATERIALS.2011.01.071, ISSN 0142-9612, (20110128), pages 3689 - 3699, (20110205), XP028369065 [Y] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.biomaterials.2011.01.071
 [T]  - HU JIAJIA ET AL, "Exosomes derived from human amniotic fluid mesenchymal stem cells alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro", CARDIOVASCULAR DIAGNOSIS AND THERAPY, (20210401), vol. 11, no. 2, doi:10.21037/cdt-20-1032, ISSN 2223-3652, pages 348 - 361, XP093043083 [T] 1-15

DOI:   http://dx.doi.org/10.21037/cdt-20-1032
 [T]  - LEE YOUNG SOOK ET AL, "Acellular human amniotic fluid protects the ischemic-reperfused rat myocardium", AMERICAN JOURNAL OF PHYSIOLOGY HEART AND CIRCULATORY PHYSIOLOGY, US, (20220301), vol. 322, no. 3, doi:10.1152/ajpheart.00331.2021, ISSN 0363-6135, pages H406 - H416, XP093086608 [T] 1-15

DOI:   http://dx.doi.org/10.1152/ajpheart.00331.2021
 [T]  - H. Javan ET AL, "(369) Acellular Human Amniotic Fluid Prevents the Development of Ischemic Heart Failure", (20230401), URL: https://www.jhltonline.org/action/showPdf?pii=S1053-2498(23)01740-0, (20230927), XP093086611 [T] 1-15
International search[A]US2016199417  (WERBER BRUCE [US], et al) [A] 1-28, 42-44 * ; see entire document *;
 [X]US2018250343  (REEMS JO-ANNA [US], et al) [X] 1-28, 42-44 * ; para [0035], [0037], [0044]-[0045], [0053]-[0054], [0061], [0075]-[0077], [0079], [0114], [0121]-[0123], [0127]-[0128], [0131], [0162], [0166] *;
 [A]US2019083547  (PETRUCCI GARY M [US]) [A] 1-28, 42-44* entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.